Moderator(s): Saeed Khayatzadeh, PhD
155. Safer way for vertebroplasty under fluid mechanics theory
Hsuan Yu Chen, MD1,2; Yen-Po Lin, MD3; Han Ying Wang, MD3; Feng Huei Lin, PhD1; Po-Quang Chen, MD, PhD4; Ding-cheng Chan, MD, PhD, FACP5; Tze Hong Wong, MD, PhD3; Ming-Hsiao Hu, MD, PhD4
1Institute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan; 2Department of Orthopedic Surgery, National Taiwan University Hospital, Hsin-Chu Biomedical Park Branch, Taipei, Taiwan; 3Department of Orthopedic Surgery, National Taiwan University Hospital, Hsin-Chu Branch, Taipei, Taiwan; 4Department of Orthopedic Surgery, Natinal Taiwan University Hospital, Taipei, Taiwan; 5National Taiwan University Hospital Chu-Tung Branch, Hsinchu County, Taiwan
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
156. Operative vs nonoperative treatment for adult symptomatic lumbar scoliosis at 5-6-year follow-up: outcomes and impact of related serious adverse events
Justin S. Smith, MD, PhD1; Michael P. Kelly, MD; Elizabeth Yanik, PhD, MSc2; Christine R. Baldus, RN3; Thomas Buell, MD4; Jon D. Lurie, MD, MS5; Charles Edwards Sr., MD6; Steven D. Glassman, MD7; Lawrence G. Lenke, MD17; Oheneba Boachie-Adjei, MD8; Jacob M. Buchowski, MD, MS9; Leah Y. Carreon, MD, MSc7; Charles H. Crawford III, MD7; Stephen J. Lewis, MD10; Stefan Parent, MD; Virginie Lafage, PhD8; Munish C. Gupta, MD11; Han Jo Kim, MD8; Christopher P. Ames, MD12; Shay Bess, MD13; Frank J. Schwab, MD8; Christopher I. Shaffrey, MD14; Keith H. Bridwell, MD15; International Spine Study Group16
1UVA Health System, Charlottesville, VA, US; 2Washington University in St. Louis, St. Louis, MO, US; 3Washington University, Department of Orthopedics, St. Louis, MO, US; 4University of Virginia Neurosurgery, Charlottesville, VA, US; 5Dartmouth College, Lebanon, NH, US; 6Baltimore, MD, US; 7Norton Leatherman Spine Center, Louisville, KY, US; 8Hospital for Special Surgery, New York, NY, US; 9Washington University School of Medicine, Saint Louis, MO, US; 10Toronto Western Hospital, Toronto, ON, Canada; 11Washington University School of Medicine, St. Louis, MO, US; 12University of California, San Francisco, San Francisco, CA, US; 13Denver, CO, US; 14Duke University, Durham, NC, US; 15Washington University In St. Louis School of Medicine, Saint Louis, MO, US; 16Brighton, CO, US;17Columbia University Department of Orthopedic Surgery, New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
157. Do cells matter? In vitro and in vivo analysis of autograft viability
Gregory M. Mundis Jr.,1; Frank Vizesi, PhD, PhD2; Nick Russell, PhD3; Jiawei He, PhD2
1Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 2SeaSpine, Carlsbad, CA, US; 3Carlsbad, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
158. The effects of a single injection of NTG-101 upon neurotrophin expression in a canine model of degenerative disc disease
William Mark Erwin, DC, PhD1; Ajay Matta, PhD2; Muhammad Zia Karim, DVM2; Hoda Gerami, BS3; Bettina Zoe Benigno, BS4
1Dept of Surgery, Univ of Toronto, Toronto, ON, Canada; 2Notogen, Toronto, ON, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
159. Efficacy of surgical decompression in patients with cervical spondylotic myelopathy results of the Canadian prospective multi-center study
Mohammed Karim, MD1; Bradley Jacobs, MD, FRCSC2; Michael G. Johnson, MD, FRCSC3; Christopher S. Bailey, MD, FRCSC4; Sean D. Christie, MD5; Jérôme Paquet, MD, FRCSC6; Andrew Nataraj, MSc, MD, FRCSC7; David W. Cadotte, MD, PhD2; Jefferson Wilson, MD, PhD, FRCSC8; Neil A. Manson, MD, FRCSC9; Hamilton Hall, MD, FRCSC10; Kenneth C. Thomas, MD, FRCS2; Raja Y. Rampersaud, MD, FRCSC11; Greg McIntosh, BS12; Charles G. Fisher, MD, FRCSC, MHS1; Nicolas Dea, MD, MSc, FRCSC1
1Combined Neurosurgery and Orthopaedic Spine Program, University of British Columbia, Vancouver, BC, Canada; 2Department of Clinical Neurosciences, Division of Neurosurgery, Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; 3Department of Surgery, Section of Orthopaedics and Neurosurgery, University of Manitoba, Winnipeg, MB, Canada;4Department of Surgery, Western University, London, ON, Canada; 5Division of Neurosurgery, Dalhousie University, Halifax, NS, Canada; 6Department of Orthopaedics, Centre Hospitalier Universitaire de Quebec, Quebec, QC, Canada; 7Division of Neurosurgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; 8Divison of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; 9Canada East Spine Centre, Saint John Regional Hospital, Saint John, NB, Canada; 10Department of Surgery, University of Toronto, Toronto, ON, Canada; 11Division of Orthopaedic Surgery and Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; 12Canadian Spine Society, Toronto, ON, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion
160. Fusion for fracture has no place in a lumbar fusion bundled payment model: an analysis of Medicare beneficiaries
Azeem T. Malik, MBBS1; Khaled Himed, BS2; Joseph Drain, MD2; Elizabeth Yu, MD2; Jeffery Kim, MD1; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
161. Cervical disc replacement using a PEEK-on-ceramic implant: prospective data from seven sites participating in an FDA IDE trial for single-level surgery
Domagoj Coric, MD1; Richard D. Guyer, MD2; Cameron N. Carmody, MD3; Rick C. Sasso, MD4; Michael J. Musacchio, MD5; Hyun W. Bae, MD6; Donna D. Ohnmeiss, PhD7
1Carolina Neurosurgery & Spine Associates, Charlotte, NC, US; 2Center for Disc Replacement at Texas Back Institute, Plano, TX, US; 3Texas Spine Consultants, Addison, TX, US; 4Indiana Spine Group, Carmel, IN, US; 5NorthShore University HealthSystem, Evanston, IL, US; 6Spine Institute St. John's Health Center, Los Angeles, CA, US; 7Texas Back Institute Research Foundation, Plano, TX, US
FDA Device/Drug Status: Simplify (Investigational/Not approved)
162. Two-level cervical disc replacement using a PEEK-on-ceramic device: prospective outcome data from an FDA IDE trial
Richard D. Guyer, MD1; Pierce D. Nunley, MD2; K. Brandon Strenge, MD3; Donna D. Ohnmeiss, PhD4
1Center for Disc Replacement at Texas Back Institute, Plano, TX, US; 2Spine Institute of Louisiana, Shreveport, LA, US; 3The Orthopaedic Institute of Western Kentucky, Paducah, KY, US; 4Texas Back Institute, Plano, TX, US
FDA Device/Drug Status: Simplify disc (Investigational/Not approved)
163. Predicting severe clinically relevant distal junctional kyphosis development following adult cervical deformity surgery with further distinction from mild asymptomatic episodes
Peter G. Passias, MD1; Sara Naessig, BS2; Virginie Lafage, PhD3; Renaud Lafage, MSc3; Bassel G. Diebo, MD4; Themistocles S. Protopsaltis, MD5; Han Jo Kim, MD3; Robert K. Eastlack, MD6; Alexandra Soroceanu, MD, MPH7; Eric O. Klineberg, MD8; Robert A. Hart, MD9; Douglas C. Burton, MD10; Shay Bess, MD11; Frank J. Schwab, MD3; Christopher I. Shaffrey, MD12; Justin S. Smith, MD, PhD13; Christopher P. Ames, MD14; International Spine Study Group15
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2NYU Langone Hospital, New York NY, US; 3Hospital for Special Surgery, New York, NY, US; 4Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 5Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 6Scripps Clinic, San Diego, CA, US; 7University of Calgary, Calgary, Canada; 8UC, Davis School of Medicine, Sacramento, CA, US; 9Swedish Neuroscience Institute, Seattle, WA, US; 10University of Kansas Medical Center, Kansas City, KS, US; 11Denver, CO, US; 12Duke University, Durham, NC, US; 13UVA Health System, Charlottesville, VA, US; 14University of California, San Francisco, San Francisco, CA, US; 15Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion